A Broad Snapback — but the Money Is Still Chasing Oil, Not Compute

Market regime

The 10/20 session was the widest advance of this sequence: 3,467 advancers against 1,131 decliners, average stock +1.06%, and a tail that finally skewed right — 567 names up 3%+ versus 96 down, 218 up 5%+ versus 30 down. Average RSI lifted off the washed-out 43-46 band to 48.1. But note the composition: 2,094 of those advancers are still negative over the past month, and 314 of them rose 3%+ while sitting on a negative one-month return. This is a mean-reversion bounce out of an oversold state, not a new leadership bid. Only 1,544 of 4,683 names hold their 50-day (33%), and just 159 of 1,459 liquid stocks sit within 3% of a 52-week high. The index-level tape (SPY +0.34%, QQQ still red) tells you the buying was in the laggards.

Mega forces

1. Energy is the only asset that is both working and near highs. XLE +8.8% in a month, E&P and integrated oil both +10% at the theme level, and 25.6% of liquid energy names sit within 3% of a 52-week high — versus 7.5% in tech and 3.7% in materials. Energy carries the only near-zero average beta (0.11) in the market, which is why it keeps attracting capital as fuel costs simultaneously torpedo airlines (UAL cut guidance twice on fuel; ALK and LTM flagged the same). Higher oil is a sector rotation and a margin tax on transports and discretionary.

2. Health Care has been quietly re-rated — and 10/20 was its day. Biotech/biopharma led the tape (Oncology +4.7%, Autoimmune +3.8%, Neurology +3.7%) with XBI +3.6%. Health Care is now the #2 sector over 12 months (+43%) yet still sits -25% from its own highs with only 41% above the 50-day — a rare combination of leadership and room. Life-science tools and CROs confirm the turn (+2.4%, +2.3%).

3. Software consolidation is compressing the AI trade. Braze +51.7% on Salesforce's $47.50 all-cash bid, and enterprise cloud apps are +9.2% in a month with 60 names participating — but data-center networking (-17%), quantum (-29%) and memory/crypto-adjacent baskets are in freefall. Deal-driven M&A (MYGN +31.6%, LION +14.4%, SLN +125% earlier) is narrowing the risk premium on cheap cash-flow software while speculative compute exposure gets de-rated.

What's working / avoid

Favor: energy value, health care (biotech, tools, CRO), staples (XLP +7.1% in a month), insurance brokers, and cash-rich software with takeover appeal. Avoid: the second-derivative AI/energy-transition complex — solar equipment, fuel cells, industrial storage, lidar, rare earths and quantum are all down 20-30% in a month, and buying them on a breadth bounce is buying the bounce, not the trend. Materials are the worst-positioned sector in the market (3.7% near highs, RSI 43.9).

Strategy

The right response is not to chase the laggard rally but to use it for liquidity. Rotate out of high-beta, high-ATR names that bounced today without reclaiming a 50-day (financials and industrials have only 24-26% of names above their 50-day — the weakest structural position) into the two sectors that are actually near highs: energy and health care. A 33% breadth reading makes this a de-risking market, not a chase-the-rip market.